StockData
LIFDOTCPharmaceutical PreparationsFiscal year ends December 31

LFTD PARTNERS INC.

Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on Aug 14, 2026
$0.10+0.00 (0.00%)

Close on Oct 19, 2026

Market cap
$1.48M
P/E (TTM)
–
Dividend yield
–

LFTD PARTNERS INC. revenue by segment

By business segment

By product or service

RevenueFY2023FY2022FY2021% of revenueYoY
Hemp Products [Member]$48.06M$55.69M$31.34M93.1%-13.7%
Products to Distributors [Member]$36.72M$45.52M$21.66M71.2%-19.3%
Vapes [Member]$27.05M$29.14M$14.32M52.4%-7.2%
Edibles [Member]$15.13M$15.81M$7.42M29.3%-4.3%
Products to Wholesalers [Member]$10.73M$7.50M$4.59M20.8%+43.0%
Flower [Member]$5.19M$4.87M$1.82M10.1%+6.7%
Cartridges [Member]$4.14M$7.47M$6.05M8.0%-44.6%
Non-Hemp Products [Member]$3.55M$1.72M$316.57K6.9%+105.9%
Products to End Consumers [Member]$2.47M$3.38M$1.69M4.8%-26.7%
Products to Private Label Clients [Member]$1.50M$975.20K$3.25M2.9%+53.9%
Customer [Member]$180.74K$40.52K$476.21K0.4%+346.1%
Apparel and Accessories [Member]$106.47K$126.00K$2.05M0.2%-15.5%

By region

From the segment and revenue-disaggregation notes of Lftd Partners's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.